Diversified Healthcare Trust (DHC)
(Delayed Data from NSDQ)
$3.68 USD
+0.04 (1.10%)
Updated Oct 11, 2024 03:59 PM ET
After-Market: $3.68 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$3.68 USD
+0.04 (1.10%)
Updated Oct 11, 2024 03:59 PM ET
After-Market: $3.68 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
Zacks News
What Makes Diversified Healthcare (DHC) a New Strong Buy Stock
by Zacks Equity Research
Diversified Healthcare (DHC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Best Value Stocks to Buy for June 2nd
by Zacks Equity Research
RCMT, DHC and CAJPY made it to the Zacks Rank #1 (Strong Buy) value stocks list on June 2, 2023.
New Strong Buy Stocks for June 2nd
by Zacks Equity Research
DHC, AU, CPG, APAM and MUSA have been added to the Zacks Rank #1 (Strong Buy) List on June 2, 2023.
DHC vs. OFC: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
DHC vs. OFC: Which Stock Is the Better Value Option?
The Zacks Analyst Blog Highlights Commercial Vehicle Group, Kimball, 2U, M-tron Industries and Diversified Healthcare
by Zacks Equity Research
Commercial Vehicle Group, Kimball, 2U, M-tron Industries and Diversified Healthcare are included in this Analyst Blog.
These 5 Small-Cap Stocks Could Be Worth Picking Up
by Sejuti Banerjea
Small-cap stocks can at times offer significant growth opportunity that is not possible from more mature companies.
Best Value Stocks to Buy for May 30th
by Zacks Equity Research
DHC, MT and RYI made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 30, 2023.
New Strong Buy Stocks for May 30th
by Zacks Equity Research
DHC, MT, ATR, RYI and APAM have been added to the Zacks Rank #1 (Strong Buy) List on May 30, 2023.
New Strong Buy Stocks for May 25th
by Zacks Equity Research
DHC, CPG, NVR, RYI and APAM have been added to the Zacks Rank #1 (Strong Buy) List on May 25, 2023.
Best Value Stocks to Buy for May 25th
by Zacks Equity Research
CPG, BAMXF and DHC made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 25, 2023.
New Strong Buy Stocks for May 22nd
by Zacks Equity Research
DHC, BAMXF, MAR, ATR and RYI have been added to the Zacks Rank #1 (Strong Buy) List on May 22, 2023.
Diversified Healthcare (DHC) Shows Fast-paced Momentum But Is Still a Bargain Stock
by Zacks Equity Research
Diversified Healthcare (DHC) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Best Growth Stocks to Buy for May 18th
by Zacks Equity Research
DHC, PERI and PHM made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 18, 2023.
Diversified Healthcare (DHC) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
by Zacks Equity Research
Diversified Healthcare (DHC) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Diversified Healthcare (DHC) Loses -18.22% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
The heavy selling pressure might have exhausted for Diversified Healthcare (DHC) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
New Strong Buy Stocks for May 16th
by Zacks Equity Research
KMT, IDCC, SAND, DHC and ASTE have been added to the Zacks Rank #1 (Strong Buy) List on May 16, 2023.
Best Growth Stocks to Buy for May 16th
by Zacks Equity Research
DHC, PERI and EZPW made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 16, 2023.
Best Value Stocks to Buy for May 16th
by Zacks Equity Research
DHC, AGCO and PERI made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 16, 2023.
DHC or OFC: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
DHC vs. OFC: Which Stock Is the Better Value Option?
Down -18.08% in 4 Weeks, Here's Why Diversified Healthcare (DHC) Looks Ripe for a Turnaround
by Zacks Equity Research
Diversified Healthcare (DHC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Diversified Healthcare (DHC) Matches Q1 FFO Estimates
by Zacks Equity Research
Diversified Healthcare (DHC) delivered FFO and revenue surprises of 0% and 0.79%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Postal Realty Trust (PSTL) Surpasses Q1 FFO and Revenue Estimates
by Zacks Equity Research
Postal Realty Trust (PSTL) delivered FFO and revenue surprises of 8% and 0.95%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Diversified Healthcare (DHC) Tops Q4 FFO Estimates
by Zacks Equity Research
Diversified Healthcare (DHC) delivered FFO and revenue surprises of 400% and 0.86%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Modiv Inc. (MDV) Surpasses Q4 FFO and Revenue Estimates
by Zacks Equity Research
Modiv Inc. (MDV) delivered FFO and revenue surprises of 106.06% and 30.18%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for December 30th
by Zacks Equity Research
DHC, PLMR and WEBR have been added to the Zacks Rank #5 (Strong Sell) List on December 30, 2022.